v3.22.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 70,688 $ 106,084
Short-term investments 260,623 264,984
Restricted cash 1,346 194
Accounts receivable 637 986
Prepaid expenses and other current assets 13,690 12,373
Total current assets 346,984 384,621
Property and equipment, net 8,328 53,780
Operating lease assets 73,582 26,159
Restricted cash - long-term 0 1,200
Other assets 7,227 2,367
Total assets 436,121 468,127
Current liabilities:    
Accounts payable 12,799 17,368
Accrued compensation 16,317 25,150
Accrued research and development expenses 15,125 13,451
Deferred revenue 1,671 40,760
Other current liabilities 19,776 9,057
Total current liabilities 65,688 105,786
Deferred revenue - long-term 43,329 55,708
Operating lease liabilities - long-term 63,999 25,518
Other long-term liabilities 5,626 1,501
Total liabilities 178,642 188,513
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Common stock-$0.0001 par value, 500,000 shares authorized as of June 30, 2022 and December 31, 2021; 94,356 and 91,671 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 9 9
Additional paid-in capital 1,794,449 1,744,695
Accumulated other comprehensive (loss) income (2,618) (368)
Accumulated deficit (1,534,361) (1,464,722)
Total stockholders’ equity 257,479 279,614
Total liabilities and stockholders’ equity $ 436,121 $ 468,127

Source